Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

Share Price is delayed by 15 minutes
Get Live Data
190.00    9.00 (4.74%)
Bid:
185.00
Ask:
195.00
Spread: 10.00 (5.405%)
Market Cap: £105.12m
SOM Live PriceLast checked at - London Stock Exchange

Intraday Somero Share Chart

Trading Update

17 Jul 2012 07:00

RNS Number : 8099H
Somero Enterprises Inc.
17 July 2012
 



PRESS ANNOUNCEMENT

17 July 2012

Somero Enterprises, Inc®

Trading Update

Somero Enterprises, Inc (the "Company") is pleased to announce that the strong trading experienced by the Company in the first quarter of 2012 has continued into the second quarter. Revenues for H1 2012 are now expected to be some 50% ahead of those reported in H1 2011. As a result of this increased sales volume, EBITDA achieved in H1 2012 is expected to be slightly ahead of the market's forecasts for the Group's entire full year performance.

 

North America showed strong growth in the first half, benefitting from mild weather conditions and a benign economic environment. Performance during this period from the Chinese business was also strong, reflecting the investment made by the Company in the region. Sales from the Company's new product the S-840 and the SXPD large line machines were significantly higher than in the same period last year. Whilst the Company still anticipates strong trading from these regions/products, it is likely that respective rates of growth are slower in the second half of the year consistent with previous years.

 

With healthy demand continuing, the Company is implementing plans to add some costs in new product development, training, marketing and sales initiatives to take full advantage of a stronger sales environment. This is intended to put Somero in the best position to deliver growth in the medium and longer term, as well as to sustain the shorter term recovery that is evident in 2012. At this stage, the Board expects that the increased costs will lead to second half profitability being lower than the first half, albeit that the outturn for the full year is still expected to be substantially ahead of current forecasts for 2012.

 

 

For further information, please contact:

Somero Enterprises, Inc

Jack Cooney, CEO

Mike Niemela, CFO

 

Tel: +1 239 210 6507

Canaccord Genuity Hawkpoint (Nominated Adviser)

Chris Robinson

Serge Rissi

 

Tel: +44 20 7665 4500

 

Canaccord Genuity Limited (Broker)

Piers Coombs

Seb Jones

Tel: +44 20 7523 8000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBKODQPBKKDOD
Date   Source Headline
21st Jun 20079:16 amRNSResult of AGM
14th Jun 20071:32 pmRNSRe: Annual Report & Accounts
12th Jun 20079:51 amRNSHolding(s) in Company
11th Jun 20075:31 pmRNSDirector/PDMR Shareholding
7th Jun 20075:52 pmRNSHolding(s) in Company
8th May 20077:02 amRNSDirector/PDMR Shareholding
4th May 20075:40 pmRNSHolding(s) in Company
4th May 20075:40 pmRNSHolding(s) in Company
1st May 20077:03 amRNSSecondary Placing
27th Apr 20072:43 pmRNSHolding(s) in Company
17th Apr 20075:31 pmRNSRe: Dividend
17th Apr 200711:12 amRNSRe: Dividend
16th Apr 20077:01 amRNSFinal Results
2nd Apr 20077:01 amRNSRe Loan Facility
28th Mar 20075:22 pmRNSHolding(s) in Company
27th Mar 20074:54 pmRNSHolding(s) in Company
26th Mar 20072:11 pmRNSHolding(s) in Company
26th Mar 20072:11 pmRNSHolding(s) in Company
26th Mar 20072:07 pmRNSHolding(s) in Company
22nd Feb 20075:26 pmRNSHolding(s) in Company
19th Feb 20073:13 pmRNSHolding(s) in Company
12th Jan 20077:01 amRNSPeriod-end Update
10th Jan 20075:14 pmRNSHolding(s) in Company
14th Nov 20064:48 pmRNSShare Transfer: 144a ISIN
8th Nov 20069:28 amRNSHolding(s) in Company
6th Nov 20065:31 pmRNSHolding(s) in Company
1st Nov 20068:05 amRNSAdmission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.